Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

This was the stock's second consecutive day of losses.

The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of ...

Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...

Boston Scientific’s Operating Cash Flow (OCF) for the same period was $3.8 billion, indicating a good OCF margin of 21.7% compared to the S&P 500’s 14.9%.

Boston Scientific insiders own 0.2% of the company, currently worth about US$267m based on the recent share price.

However, that’s separate from Boston Scientific’s ongoing plans to build and grow into a wholly new Maple Grove site, with a $170 million, 400,000-square-foot project that the Star Tribune ...

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options become available today, for the February 2026 expiration. One of the key data points that goes into the price an option buyer is ...

The firm initiated Boston Scientific and Medtronic with Outperform ratings, citing company-specific catalysts and improving fundamentals, and set price targets of $118 and $110, respectively. Abbott ...

Tech power players like Sam King are leading the way in Greater Boston's software and cloud industry. Learn more in our 2025 list of New England's top tech leaders.

Boston Scientific Down Over 7%, on Pace for Largest Percent Decrease Since November 2020 — Data Talk Global News Select Apr 4, 2025, 9:41:00 AM ...

Boston Scientific agreed to pay Johnson & Johnson $600 million in connection with Johnson & Johnson’s botched acquisition of Guidant, a medical device company, in 2004. By David Gelles DealBook ...